Guardant (United States)
In research, Guardant (United States) stands highest in Medicine (#8,793 of 10,443 worldwide), Health Sciences (#10,618 of 11,982 worldwide) and Life Sciences (#7,575 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research, Oncology and Pulmonary and Respiratory Medicine — Cancer Research is 59.8× its share of world research.
- World rank, 2022–2025
- #24,279 of 28,054 · #31,556 all time
- Rank in United States
- #3,646 of 4,192
- Research works
- 371 ▲ 220% vs 2013–17
- Citations
- 5.3k 14.2 per fractional work
- Top-10% rate
- 8.1% record average 16.5%
- Open access
- 28% world 28%
What is Guardant (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #8,793 of 10,443 | 9.8% | 78 | #12341 | |
| Health SciencesDomain | #10,618 of 11,982 | 9.8% | 78 | #15533 | |
| Life SciencesDomain | #7,575 of 7,800 | 6.5% | 63 | #13524 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,572 of 3,579 | 6.5% | 62 | #7642 |
Each strip is that field’s whole ranked pool, with the notch where Guardant (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#12,341 #8,793
- Health Sciences#15,533 #10,618
- Life Sciences#13,524 #7,575
- Biochemistry, Genetics and Molecular Biology#7,642 #3,572
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Guardant (United States) specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 59.8× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 38.3 works60×
- OncologySubfield · 28.7 works17×
- Pulmonary and Respiratory MedicineSubfield · 24.7 works11×
- Biochemistry, Genetics and Molecular BiologyField · 61.6 works7.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.8×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.8×
- Medicine 2.8×
- Mathematics 0.7×
- Immunology and Microbiology 0.6×
- Decision Sciences 0.5×
- Economics, Econometrics and Finance 0.2×
- Computer Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Neuroscience 0.1×
- Health Professions 0.0×
- Engineering 0.0×
- Physics and Astronomy 0.0×
- Psychology 0.0×
- Environmental Science 0.0×
Who are the top researchers at Guardant (United States)?
Ranked on the composite score, Justin I. Odegaard, AmirAli Talasaz and Lesli A. Kiedrowski lead among researchers whose main affiliation is Guardant (United States).
- 1 Justin I. Odegaard United States · #75,302 worldwide 310 citations · 37 works
- 2 AmirAli Talasaz United States · #172,518 worldwide 105 citations · 33 works
- 3 Lesli A. Kiedrowski United States · #255,038 worldwide 123 citations · 18 works
- 4 Darya Chudova United States · #364,374 worldwide 51 citations · 22 works
- 5 Victoria M. Raymond United States · #390,394 worldwide 117 citations · 36 works
- 6 Martina I. Lefterova United States · #409,598 worldwide 181 citations · 15 works
- 7 Kimberly C. Banks United States · #575,567 worldwide 65 citations · 26 works
- 8 Richard B. Lanman United States · #600,591 worldwide 156 citations · 71 works
- 9 Rebecca J. Nagy United States · #672,817 worldwide 57 citations · 42 works
- 10 Katie Quinn United States · #1,446,009 worldwide 4 citations · 22 works
Which keywords describe research at Guardant (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Genomic Instability, Somatic Mutations, Cell-Free DNA, Cancer Genomics, Mutational Signatures, Chemotherapy and Clinical Trials.
- Homologous Recombination
- Adjuvant Therapy
- Cell Death
- DNA Methylation
- Fluorouracil
- BRAF Mutation
- Prognostic Factors
- Breast Cancer
- Cetuximab
- Gene Expression
- Microsatellite Instability
- Cancer
- Immunotherapy
- Cancer Risk
- Molecular Characterization
- ALK Inhibitors
- Clinical Trials
- Somatic Mutations
- Cell-Free DNA
- Genomic Instability
- Targeted Therapy
- Cancer Genomics
- Mutational Signatures
- Chemotherapy
- Genomic Profiling
- EGFR Mutations
- Precision Medicine
- Genetic Testing
- Adjuvant Chemotherapy
- Hereditary Syndromes
- Tumor Microenvironment
- Biomarkers
- Risk Factors
- Molecular Subtypes
- Metastasis
- Radiotherapy
- KRAS Mutations
- Histone Modification
- Genetic Mutations
- Neoadjuvant Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Targeted Therapy49▲ 150×4 topics
- Genomic Instability36▲ 219×2 topics
- Cancer Genomics35▲ 324×1 topic
- Cell-Free DNA35▲ 238×2 topics
- Mutational Signatures35▲ 324×1 topic
- Somatic Mutations35▲ 285×2 topics
- Chemotherapy18▲ 17×14 topics
- Clinical Trials17▲ 17×6 topics
- Genomic Profiling14▲ 93×2 topics
- ALK Inhibitors12▲ 127×1 topic
- EGFR Mutations12▲ 127×1 topic
- Molecular Characterization10▲ 39×4 topics
- Precision Medicine10▲ 15×5 topics
- Cancer Risk9▲ 29×2 topics
- Genetic Testing9▲ 56×2 topics
- Immunotherapy9▲ 9.0×14 topics
- Adjuvant Chemotherapy8▲ 76×2 topics
- Cancer8▲ 3.9×15 topics
- Hereditary Syndromes7▲ 163×1 topic
- Microsatellite Instability7▲ 163×1 topic
- Tumor Microenvironment7▲ 11×7 topics
- Gene Expression7▲ 7.5×7 topics
- Biomarkers7▲ 6.5×7 topics
- Cetuximab6▲ 52×2 topics
- Risk Factors6▲ 3.8×4 topics
- Breast Cancer6▲ 17×6 topics
- Molecular Subtypes6▲ 48×2 topics
- Prognostic Factors6▲ 8.5×9 topics
- Metastasis5▲ 11×7 topics
- BRAF Mutation5▲ 50×2 topics
- Radiotherapy5▲ 9.1×6 topics
- Fluorouracil5▲ 107×1 topic
- KRAS Mutations5▲ 107×1 topic
- DNA Methylation5▲ 28×1 topic
- Histone Modification5▲ 47×1 topic
- Cell Death4▲ 13×2 topics
- Genetic Mutations4▲ 6.9×7 topics
- Adjuvant Therapy4▲ 23×2 topics
- Neoadjuvant Therapy4▲ 12×5 topics
- Homologous Recombination4▲ 60×2 topics
Which research topics does Guardant (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Genetic factors in colorectal cancer and Colorectal Cancer Treatments and Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 35 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 12 works
- 3 Genetic factors in colorectal cancer Pathology and Forensic Medicine 7 works
- 4 Colorectal Cancer Treatments and Studies Oncology 5 works
- 5 Epigenetics and DNA Methylation Molecular Biology 5 works
- 6 RNA modifications and cancer Molecular Biology 3 works
- 7 Global Cancer Incidence and Screening Oncology 3 works
- 8 PARP inhibition in cancer therapy Oncology 3 works
- 9 Colorectal Cancer Screening and Detection Oncology 3 works
- 10 Molecular Biology Techniques and Applications Molecular Biology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Guardant (United States)'s research output changed?
Output in 2018–2022 was 220% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Redwood City
- Heron Therapeutics (United States)
- Chan Zuckerberg Initiative (United States)
- Emergency University
- Box (United States)
- OncoMed (United States)
- Genomic Health (United States)
- Ubiquitous Energy (United States)
- Maxygen (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.